Europe

Wed
16
Oct

Europe could lose more ground in the medicinal cannabis industry

Europe is at risk of losing the market share to Africa in the medicinal cannabis industry, and Eco Equity have spotted the global potential.

There is a reluctance by some European policy and law makers to embrace the economic potential of medicinal cannabis and as a result they are seeing opportunities lost to more progressive markets. Europe could lose more ground following Lesotho and Zimbabwe’s decisions to allow cultivation of medicinal cannabis for mass export.

Thu
10
Oct

New call for unified global CBD testing standards

New standardized purity tests would prevent unscrupulous CBD companies gaming the system to secure favorable results, says a U.K. industry body.

The London-based Centre for Medicinal Cannabis (CMC) is to gauge the appetitive for a new set of internationally-recognized CBD testing guidelines. In a press release the CMC says it has appointed leading chemist Dr Parveen Bhatarah, to investigate how to overcome the ‘barriers to analytical method standardization in the CBD-space’.

Recent research from the CMC highlighted the size of the problem currently facing the industry.

Thu
10
Oct

European legal cannabis a "prime investment target" for North American money

European cannabis has become a “prime investment target for excess cash” for North American firms emboldened by high valuations in USA, a sector expert says.

Ben Langley, chief executive of investment company Grow Biotech, said that a “steady wave of capital flowing to Europe” is starting to roll across the Atlantic from entrepreneurs and investors who have “cash to deploy, global ambitions, and experience operating in ‘legal’ markets”.

According to broker Liberum, cannabis sector fundraising in UK has only reached £45mln year-to-date, “a drop in the ocean” compared to the £30bn raised in North America.

Mon
07
Oct

20,000 German pharmacies to stock Canadian Firm’s cannabis

The first European deal for Canadian firm MediPharm Labs will see its medical cannabis products made available to 20,000 German pharmacies.

With dual listings on the Ontario and Frankfurt stock exchanges, MediPharm says this new deal is an important milestone in its global ambitions.

Mon
07
Oct

Is European Cannabis Holdings preparing for flotation?

One of the leading lights of the European cannabis scene has successfully completed its demerger – as speculation mounts that a stock market flotation is imminent.

Fri
27
Sep

Epidyolex approved for use in over 30 European Countries

Patients in over 30 European countries could soon be able to get access to GW Pharmaceuticals Epidyolex cannabis medicine after it was approved by the European Commission.

Since its launch in the U.S last year GW’s sales have rocketed with Epidiolex (as it is known in America) boosting its revenues by over $30m in its first quarter, with more than 7,600 patients accessing the drug.

Now the European Medicines Agency has approved marketing authorisation in the 28 member states of the European Union, for its use for two conditions associated with childhood epilepsy; Lennox‑Gastaut syndrome and Dravet syndrome.

Thu
19
Sep

European cannabis THC levels have doubled in ten years

Cannabis potency in Europe has risen dramatically with THC levels more than doubling in a decade.

And, cannabis remains the most widely used ‘illicit’ drug in Europe, show findings from some recent research. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) report shows that the THC concentration of ‘herbal cannabis’ doubled from 5% to 10%, from 2006 to 2016, whilst cannabis resin potency increased from 8% to 17% over the same period.

Fri
13
Sep

European novel food regulation – What’s it all about?

Makers and sellers of CBD products should be conforming to the European Union’s Novel Food regime introduced in January this year.

But, as things stand, just one firm Cannabis Pharma, a Czech Republic company, has made an application to the European Food Safety Authority (EFSA), with a handful of others said to be in the pipeline.

Mon
09
Sep

First Colombian CBD exports shipped to Europe

The first two batches of Colombian CBD have been exported to Europe as the South American country steps-up efforts to become a leading global player.

The Colombian government recently granted its first CBD isolate export permit to PharmaCielo and it has now shipped its first batch to the Swiss firm Creso Pharma. Meanwhile, Bogota-based Clever Leaves has successfully cleared U.K. customs with a batch of Colombian CBD destined for the booming British retail market.

Wed
04
Sep

Hemp cultivation in Europe

Hemp cultivation in Europe is well established with a tradition dating back hundreds of years. Currently, it is estimated that Europe cultivates up to 25% of the world's hemp. France alone accounted for 40% of the European production, with at least 20 other countries contributing to the European Union's total.

European hemp cultivation has been on a major upswing for the last several years, as producers and consumers become more excited about new usage opportunities.

Pages

Subscribe to RSS - Europe